II
Immunophotonics, Inc.
SEC filingPharmaceuticals · St. Louis, MO
Amount raised$10.1Msold at filing
Total offeringNot stated
Investors in the raise45count reported to the SEC
FiledSep 4, 2026first sale Jul 14, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Miguel M. ZubizarretaDirector
Richard M. LevensonDirector
Luciano M. AlleruzzoDirector, Promoter
Jonathan M. KnowlesDirector
Robert H. ArchExecutive Officer
Jacqueline M. HessDirector
Wei M. ChenDirector, Promoter
Alexander Michael HurstExecutive Officer
Executive officers, directors and promoters as listed on the Form D.